King's Group Biotech 2025 Q4 Financials
NQ Score
53/100
N1 Content Completeness
3
AI Summary (NQ-processed)
King's Group Biotech Co., Ltd. announced its Q4 2025 financial results, reporting a basic EPS of 0.66 NTD. The company achieved an operating revenue of 401 million NTD and a net profit after tax of 48 million NTD.
AI analysis data is not yet available.